Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 42.02%: Here's is How to Trade

Castle Biosciences, Inc. (CSTL) closed the last trading session at $28.87, gaining 2.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $41 indicates a 42% upside potential.The average comprises nine short-term price targets ranging from a low of $32 to a high of $50, with a standard deviation of $5.22. While the lowest estimate indicates an increase of 10.8% from the current price ...